Bluefin Capital Management’s Chemours CC Stock Holding History

Bluefin Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,700	Closed	-$258K	–	706
2021 Q4	$258K	Sell	7,700 -2,250	-23%	-$70.1K	0.02%	491
2021 Q3	$289K	Buy	+9,950	New	+$322K	0.03%	398
2021 Q2	–	Sell	-16,300	Closed	-$455K	–	711
2021 Q1	$455K	Buy	+16,300	New	+$434K	0.02%	313
2018 Q2	–	Sell	-6,160	Closed	-$300K	–	427
2018 Q1	$300K	Buy	+6,160	New	+$308K	0.02%	242
2017 Q3	–	Sell	-81,076	Closed	-$3.82M	–	495
2017 Q2	$3.07M	Sell	81,076 -65,777	-45%	-$2.59M	0.33%	60
2017 Q1	$5.65M	Buy	+146,853	New	+$4.42M	0.74%	24
2016 Q1	–	Sell	-75,737	Closed	-$406K	–	502
2015 Q4	$406K	Buy	+75,737	New	+$484K	0.03%	332

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bluefin Capital Management's CC Position: Q1 2022 in Review

Bluefin Capital Management sold out of Chemours (CC) in Q1 2022, closing a stake of 7,700 shares — an estimated $258K sold.

Bluefin Capital Management first reported a position in CC in Q4 2015 and held it in 7 quarters. The position peaked at $5.65M in Q1 2017. 482 funds tracked by Wall St. Rank hold CC as of Q1 2022.

Bluefin Capital Management reported no remaining Chemours position as of Q1 2022 after selling out during the quarter.
Bluefin Capital Management sold 7,700 Chemours shares in Q1 2022, an estimated $258K.
Bluefin Capital Management first reported a position in Chemours in Q4 2015 and held it in 7 quarters.
Bluefin Capital Management's Chemours position peaked at $5.65M in Q1 2017.
482 funds tracked by Wall St. Rank held Chemours as of Q1 2022.

Based on Bluefin Capital Management's 13F filing for Q1 2022, filed 16 May 2022.